Opportunity BasketGLP-1 Patient Financing & Bulk Procurement Cooperative
A membership-based cooperative that aggregates patient demand across multiple clinics and direct-to-consumer channels, then negotiates bulk pricing directly with pharmaceutical manufacturers and authorized wholesalers. Members (patients + participating clinics) pay a monthly membership fee; the cooperative secures volume discounts (typically 30-50% off retail) by committing to minimum quarterly purchases, then passes savings to members while retaining a margin.
44 weeks • 70% confidence
Value Proposition
Reduces patient out-of-pocket cost from $900-1,500/month to $400-600/month through legitimate bulk purchasing power. Clinics gain a patient loyalty tool and operational efficiency (cooperative handles prior-auth coordination, inventory management, patient education). Beats existing solutions because it's not a marketplace (no intermediary markup), not a discount card (no negotiating power), and not a pharmaceutical assistance program (no income caps, faster access).
Target Audience
Patients with obesity/metabolic disorders earning $40k-$150k annually who have insurance that won't cover or has high copays; mid-size primary care and obesity-specialist clinics (20-100 providers) seeking to differentiate and improve patient retention
Key Features
- Negotiated tiered pricing with 3-5 major wholesalers based on monthly volume commitments
- Patient membership portal showing real-time pricing, clinic network, and refill scheduling
- Clinic integration layer: EDR/EHR connectors (HL7 standard) for automated patient eligibility and refill workflows
- And more, with full implementation detail...
Tech Stack
Unlock the full solution
You're seeing a preview. Unlock the complete value proposition, every feature, the full tech stack, the monetization model, and the week-by-week build roadmap, plus a downloadable PDF.
Sign up free to continue3 free solution credits on signup
The build plan is behind the wall
Subscribers get the full monetization model, pricing strategy, and the complete week-by-week roadmap to build this.
Sign up freeOriginal Problem
Patients struggle to access effective weight loss medications due to supply constraints and high costsPeople with obesity and metabolic disorders face critical barriers to GLP-1 medications: extreme scarcity of existing drugs (Ozempic, Wegovy), astronomical out-of-pocket costs ($900-1,500/month), and long waitlists. Current solutions are either unavailable or financially inaccessible, forcing patients to delay treatment while pharmaceutical companies race to develop alternatives, creating a desperate market willing to pay premium prices for any viable option.
Score: 56.4% • 2 payment signals